DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 1970-1980

  Sumpter, Tina L ^a,b   Packiam, Vignesh ^a,b   Turnquist, Heth R ^a,b   Castellaneta, Antonino ^a,b   Yoshida, Osamu ^a,b   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; LIVER CELL; LUNG ALVEOLUS CELL; MALE; MOLECULAR DYNAMICS; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHO CELLS; COCULTURE TECHNIQUES; CRICETINAE; CRICETULUS; DENDRITIC CELLS; GROWTH INHIBITORS; IMMUNE TOLERANCE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-10; LIVER; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; T-LYMPHOCYTES;

EID: 79951832367     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000527     Document Type: Article

References (82)

1. Knolle, P. A., and G. Gerken. 2000. Local control of the immune response in the liver. Immunol. Rev. 174: 21-34.
2. Lau, A. H., and A. W. Thomson. 2003. Dendritic cells and immune regulation in the liver. Gut 52: 307-314.
3. Bowen, D. G., M. Zen, L. Holz, T. Davis, G. W. McCaughan, and P. Bertolino. 2004. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J. Clin. Invest. 114: 701-712.
4. Crispe, I. N. 2009. The liver as a lymphoid organ. Annu. Rev. Immunol. 27: 147-163.
5. Sumpter, T. L., M. Abe, D. Tokita, and A. W. Thomson. 2007. Dendritic cells, the liver, and transplantation. Hepatology 46: 2021-2031.
6. May, A. G., S. Bauer, J. P. Leddy, B. Panner, J. Vaughan, and P. S. Russell. 1969. Survival of allografts after hepatic portal venous administration of specific transplantation antigen. Ann. Surg. 170: 824-832.
7. Qian, J., T. Hashimoto, H. Fujiwara, and T. Hamaoka. 1985. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells. J. Immunol. 134: 3656-3661.
8. Cantor, H. M., and A. E. Dumont. 1967. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215: 744-745.
9. Qian, S., A. J. Demetris, N. Murase, A. S. Rao, J. J. Fung, and T. E. Starzl. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19: 916-924.
10. Farges, O., P. J. Morris, and M. J. Dallman. 1994. Spontaneous acceptance of liver allografts in the rat. Analysis of the immune response. Transplantation 57: 171-177.
11. Calne, R. Y., R. A. Sells, J. R. Pena, D. R. Davis, P. R. Millard, B. M. Herbertson, R. M. Binns, and D. A. Davies. 1969. Induction of immunological tolerance by porcine liver allografts. Nature 223: 472-476.
12. Lu, L., J. Woo, A. S. Rao, Y. Li, S. C. Watkins, S. Qian, T. E. Starzl, A. J. Demetris, and A. W. Thomson. 1994. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J. Exp. Med. 179: 1823-1834.
13. O'Connell, P. J., A. E. Morelli, A. J. Logar, and A. W. Thomson. 2000. Phenotypic and functional characterization of mouse hepatic CD8 alpha+ lymphoidrelated dendritic cells. J. Immunol. 165: 795-803.
14. Tokita, D., T. L. Sumpter, G. Raimondi, A. F. Zahorchak, Z. Wang, A. Nakao, G. V. Mazariegos, M. Abe, and A. W. Thomson. 2008. Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J. Hepatol. 49: 1008-1018.
15. Pillarisetty, V. G., A. B. Shah, G. Miller, J. I. Bleier, and R. P. DeMatteo. 2004. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J. Immunol. 172: 1009-1017.
16. You, Q., L. Cheng, R. M. Kedl, and C. Ju. 2008. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 48: 978-990.
17. Winau, F., G. Hegasy, R. Weiskirchen, S. Weber, C. Cassan, P. A. Sieling, R. L. Modlin, R. S. Liblau, A. M. Gressner, and S. H. Kaufmann. 2007. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26: 117-129.
18. Limmer, A., J. Ohl, G. Wingender, M. Berg, F. Jüngerkes, B. Schumak, D. Djandji, K. Scholz, A. Klevenz, S. Hegenbarth, et al. 2005. Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur. J. Immunol. 35: 2970-2981.
19. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
20. Thomson, A. W., and L. Lu. 1999. Are dendritic cells the key to liver transplant tolerance? Immunol. Today 20: 27-32. (Pubitemid 29136547)
21. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621.
22. Bamboat, Z. M., L. M. Ocuin, V. P. Balachandran, H. Obaid, G. Plitas, and R. P. DeMatteo. 2010. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J. Clin. Invest. 120: 559-569.
23. Xia, S., Z. Guo, X. Xu, H. Yi, Q. Wang, and X. Cao. 2008. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood 112: 3175-3185.
24. Khanna, A., A. E. Morelli, C. Zhong, T. Takayama, L. Lu, and A. W. Thomson. 2000. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J. Immunol. 164: 1346-1354.
25. Bamboat, Z. M., J. A. Stableford, G. Plitas, B. M. Burt, H. M. Nguyen, A. P. Welles, M. Gonen, J. W. Young, and R. P. DeMatteo. 2009. Human liver dendritic cells promote T cell hyporesponsiveness. J. Immunol. 182: 1901-1911.
26. Watanabe, T., H. Katsukura, T. Chiba, T. Kita, and Y. Wakatsuki. 2007. Periportal and sinusoidal liver dendritic cells suppressing T helper type 1-mediated hepatitis. Gut 56: 1445-1451. (Pubitemid 47517842)
27. Liang, X., L. Ma, N. L. Thai, J. J. Fung, S. Qian, and L. Lu. 2007. The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes. Immunology 120: 251-260. (Pubitemid 46046323)
28. Lu, L., W. A. Rudert, S. Qian, D. McCaslin, F. Fu, A. S. Rao, M. Trucco, J. J. Fung, T. E. Starzl, and A. W. Thomson. 1995. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 182: 379-387.
29. Ohnmacht, C., A. Pullner, S. B. King, I. Drexler, S. Meier, T. Brocker, and D. Voehringer. 2009. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206: 549-559.
30. De Creus, A., M. Abe, A. H. Lau, H. Hackstein, G. Raimondi, and A. W. Thomson. 2005. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 174: 2037-2045.
31. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30: 475-487.
32. Abe, M., D. Tokita, G. Raimondi, and A. W. Thomson. 2006. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur. J. Immunol. 36: 2483-2493.
33. Mashreghi, M. F., R. Klemz, I. S. Knosalla, B. Gerstmayer, U. Janssen, R. Buelow, A. Jozkowicz, J. Dulak, H. D. Volk, and K. Kotsch. 2008. Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3. J. Immunol. 180: 7919-7930.
34. Lunz, J. G., III, S. M. Specht, N. Murase, K. Isse, and A. J. Demetris. 2007. Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 46: 1946-1959.
35. Aoki, N., S. Kimura, Y. Takiyama, Y. Atsuta, A. Abe, K. Sato, and M. Katagiri. 2000. The role of the DAP12 signal in mouse myeloid differentiation. J. Immunol. 165: 3790-3796. (Pubitemid 32057285)
36. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
37. Tomasello, E., and E. Vivier. 2005. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur. J. Immunol. 35: 1670-1677.
38. Lanier, L. L. 2009. DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev. 227: 150-160.
39. Turnbull, I. R., and M. Colonna. 2007. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 7: 155-161.
40. Hamerman, J. A., N. K. Tchao, C. A. Lowell, and L. L. Lanier. 2005. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. [Published erratum appears in 2009 Nat. Immunol. 10: 223.] Nat. Immunol. 6: 579-586.
41. Hall, H. T., H. Sjölin, H. Brauner, E. Tomasello, M. Dalod, E. Vivier, and P. Höglund. 2008. Increased diabetes development and decreased function of CD4+CD25+ Treg in the absence of a functional DAP12 adaptor protein. Eur. J. Immunol. 38: 3191-3199.
42. Turnbull, I. R., J. E. McDunn, T. Takai, R. R. Townsend, J. P. Cobb, and M. Colonna. 2005. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J. Exp. Med. 202: 363-369.
43. Bakker, A. B., R. M. Hoek, A. Cerwenka, B. Blom, L. Lucian, T. McNeil, R. Murray, L. H. Phillips, J. D. Sedgwick, and L. L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13: 345-353.
44. Tomasello, E., P. O. Desmoulins, K. Chemin, S. Guia, H. Cremer, J. Ortaldo, P. Love, D. Kaiserlian, and E. Vivier. 2000. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13: 355-364.
45. Chu, C. L., Y. L. Yu, K. Y. Shen, C. A. Lowell, L. L. Lanier, and J. A. Hamerman. 2008. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma. Eur. J. Immunol. 38: 166-173.
46. Sjölin, H., S. H. Robbins, G. Bessou, A. Hidmark, E. Tomasello, M. Johansson, H. Hall, F. Charifi, G. B. Karlsson Hedestam, C. A. Biron, et al. 2006. DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J. Immunol. 177: 2908-2916. (Pubitemid 44277806)
47. Divangahi, M., T. Yang, K. Kugathasan, S. McCormick, S. Takenaka, G. Gaschler, A. Ashkar, M. Stampfli, J. Gauldie, J. Bramson, et al. 2007. Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J. Immunol. 179: 4015-4026.
48. Kaifu, T., J. Nakahara, M. Inui, K. Mishima, T. Momiyama, M. Kaji, A. Sugahara, H. Koito, A. Ujike-Asai, A. Nakamura, et al. 2003. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111: 323-332.
49. Drakes, M. L., L. Lu, V. M. Subbotin, and A. W. Thomson. 1997. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J. Immunol. 159: 4268-4278.
50. Coates, P. T., B. L. Colvin, A. Ranganathan, F. J. Duncan, Y. Y. Lan, W. J. Shufesky, A. F. Zahorchak, A. E. Morelli, and A. W. Thomson. 2004. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization. Kidney Int. 66: 1907-1917.
51. Thiele, A. T., T. L. Sumpter, J. A. Walker, Q. Xu, C. H. Chang, R. L. Bacallao, R. Kher, and D. S. Wilkes. 2006. Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2. J. Virol. 80: 1826-1836.
52. Schmittgen, T. D., B. A. Zakrajsek, A. G. Mills, V. Gorn, M. J. Singer, and M. W. Reed. 2000. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285: 194-204.
53. Lumsden, A. B., J. M. Henderson, and M. H. Kutner. 1988. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232-236.
54. Li, M., H. Qian, T. E. Ichim, W. W. Ge, I. A. Popov, K. Rycerz, J. Neu, D. White, R. Zhong, and W. P. Min. 2004. Induction of RNA interference in dendritic cells. Immunol. Res. 30: 215-230.
55. Pedersen, C. D., J. J. Fang, and A. E. Pedersen. 2009. A comparative study of transfection methods for RNA interference in bone marrow-derived murine dendritic cells. Scand. J. Immunol. 70: 447-456.
56. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
57. Bouchon, A., C. Hernández-Munain, M. Cella, and M. Colonna. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194: 1111-1122.
58. Jomantaite, I., N. Dikopoulos, A. Kröger, F. Leithäuser, H. Hauser, R. Schirmbeck, and J. Reimann. 2004. Hepatic dendritic cell subsets in the mouse. Eur. J. Immunol. 34: 355-365.
59. Plitas, G., B. M. Burt, J. A. Stableford, H. M. Nguyen, A. P. Welles, and R. P. DeMatteo. 2008. Dendritic cells are required for effective cross-presentation in the murine liver. Hepatology 47: 1343-1351.
60. Roncarolo, M. G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50.
61. Levings, M. K., S. Gregori, E. Tresoldi, S. Cazzaniga, C. Bonini, and M. G. Roncarolo. 2005. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105: 1162-1169.
62. Steinbrink, K., M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159: 4772-4780.
63. De Smedt, T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27: 1229-1235.
64. Demangel, C., P. Bertolino, and W. J. Britton. 2002. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 32: 994-1002.
65. Hegde, S., J. Pahne, and S. Smola-Hess. 2004. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J. 18: 1439-1441. (Pubitemid 39561607)
66. Nefedova, Y., P. Cheng, D. Gilkes, M. Blaskovich, A. A. Beg, S. M. Sebti, and D. I. Gabrilovich. 2005. Activation of dendritic cells via inhibition of Jak2/ STAT3 signaling. J. Immunol. 175: 4338-4346.
67. Park, S. J., T. Nakagawa, H. Kitamura, T. Atsumi, H. Kamon, S. Sawa, D. Kamimura, N. Ueda, Y. Iwakura, K. Ishihara, et al. 2004. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 173: 3844-3854. (Pubitemid 39280747)
68. Klesney-Tait, J., I. R. Turnbull, and M. Colonna. 2006. The TREM receptor family and signal integration. Nat. Immunol. 7: 1266-1273.
69. Sato, K., K. Eizumi, T. Fukaya, S. Fujita, Y. Sato, H. Takagi, M. Yamamoto, N. Yamashita, A. Hijikata, H. Kitamura, et al. 2009. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood 113: 4780-4789.
70. Chen, L. C., J. D. Laskin, M. K. Gordon, and D. L. Laskin. 2008. Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp. Mol. Pathol. 84: 145-155.
71. Lagler, H., O. Sharif, I. Haslinger, U. Matt, K. Stich, T. Furtner, B. Doninger, K. Schmid, R. Gattringer, A. F. de Vos, and S. Knapp. 2009. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J. Immunol. 183: 2027-2036.
72. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458.
73. Graham, D. B., L. M. Stephenson, S. K. Lam, K. Brim, H. M. Lee, J. Bautista, S. Gilfillan, S. Akilesh, K. Fujikawa, and W. Swat. 2007. An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells. J. Exp. Med. 204: 2889-2897.
74. Rescigno, M., M. Martino, C. L. Sutherland, M. R. Gold, and P. Ricciardi- Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188: 2175-2180.
75. Hoentjen, F., R. B. Sartor, M. Ozaki, and C. Jobin. 2005. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105: 689-696. (Pubitemid 40070754)
76. Wang, L., I. Tassiulas, K. H. Park-Min, A. C. Reid, H. Gil-Henn, J. Schlessinger, R. Baron, J. J. Zhang, and L. B. Ivashkiv. 2008. 'Tuning' of type I interferoninduced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nat. Immunol. 9: 186-193.
77. Orabona, C., M. T. Pallotta, C. Volpi, F. Fallarino, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, U. Grohmann, and P. Puccetti. 2008. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc. Natl. Acad. Sci. USA 105: 20828-20833.
78. Orabona, C., E. Tomasello, F. Fallarino, R. Bianchi, C. Volpi, S. Bellocchio, L. Romani, M. C. Fioretti, E. Vivier, P. Puccetti, and U. Grohmann. 2005. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. Eur. J. Immunol. 35: 3111-3118.
79. Sun, Y., Y. E. Chin, E. Weisiger, C. Malter, I. Tawara, T. Toubai, E. Gatza, P. Mascagni, C. A. Dinarello, and P. Reddy. 2009. Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J. Immunol. 182: 5899-5903.
80. Tessarz, A. S., and A. Cerwenka. 2008. The TREM-1/DAP12 pathway. Immunol. Lett. 116: 111-116.
81. Tessarz, A. S., S. Weiler, K. Zanzinger, P. Angelisová, V. Horejsí, and A. Cerwenka. 2007. Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. J. Immunol. 178: 1991-1999. (Pubitemid 46233395)
82. Fortin, C. F., O. Lesur, and T. Fulop, Jr. 2007. Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int. Immunol. 19: 41-50.